Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)

NCT00981084 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: armodafinil

Sponsor

University of Missouri, Kansas City

Collaborators

[object Object]